Diagnosis of vertebral osteomyelitis (VO)

Blog · Infection

Diagnosis of vertebral osteomyelitis (VO)

Reference: JBJI review published on 27/1/2022. Read the full paper here – Maamari, J., Tande, A. J., Diehn, F., Tai, D. B. G., and Berbari, E. F.: Diagnosis of vertebral osteomyelitis, J. Bone Joint Infect., 7, 23–32, https://doi.org/10.5194/jbji-7-23-2022, 2022.

Biomarkers

  • CRP and ESR have the highest sensitivity (94 %–100 %), especially when used together.
  • White cell count has low sensitivity and specificity.
  • >90% of patients with VO have an ESR of >50. ESR is usually more elevated in bacterial VO compared to TB VO.
  • If fever and MRI findings, the predictive value may increase further.

Imaging

  • MRI (preferably with intravenous gadolinium contrast) is the preferred mode of imaging with high sensitivity (97%), specificity (92%), and accuracy (94%). MRI can identify marrow oedema as early as 48 hrs. However, MRI can be repeated in 2-4 weeks if the early imaging is inconclusive. Routine repeat MRI to test response may not help as the radiological response lags behind the clinical response.
  • X-ray – low sensitivity at the early stage of the disease (abnormalities appear 2 to 8 weeks after the onset of symptoms), but can be used as the initial test to rule out other pathologies and spinal enumeration. Comparison with old X-rays may help to identify subtle signs.
  • CT scan – CT could be superior to MRI in some cases -Modic type endplate changes and if clinical findings do not strongly suggest infection.
  • Nuclear imaging –
    – Scintigraphy with single-photon emission computed tomography (SPECT) using Technetium-99m (99mTc) and Gallium-67 (67Ga) tracers can be used when MRI is contraindicated.
    – Positron emission tomography–computed tomography (PET/CT) also can be used and may have similar efficacy to MRI.

Biopsy and Microbiology

  • Blood culture: positive in 58% of cases (range 30-70%). Two sets of blood cultures are recommended. Previous antibiotic therapy may affect the blood culture positivity. If a typical organism is identified (St aureus, St lugdunensis, Brucella) – further investigation is not necessary.
  • Biopsy – when blood or other cultures does not give a conclusive result, image-guided (typically CT or fluoroscopy) percutaneous biopsy or open biopsy is necessary. Open biopsy has higher yield (76%) compared to percutaneous (48-52%). Biopsy specimens should be sent for culture and histopathology.
  • Factors which increase the yield are – an elevated CRP, a lower-gauge needle, an increased number of specimens and aspiration of a fluid collection.
  • Repeat biopsy: if the initial needle biopsy is not diagnostic, a repeat needle biopsy can be undertaken after 3 days, or an open biopsy can be done.

Serology

  • Fungal serology can be considered, if risk factor present, endemic situation or clinically suspected.
  • Brucella serology: if Brucella is suspected – Blood culture and serology should be used for diagnosis. A cutoff of > 1 : 160 for Brucella antibodies or > 1 : 320 for the Coombs test is considered positive.
  • TB: a purified protein derivative test or an interferon-γ release assay could be used for their high negative predictive value.

Novel modalities

  • Low-tesla open-magnet MRI scanners – 86 % sensitivity with a 100 % specificity for MRI-guided biopsies.
  • 16S ribosomal RNA (rRNA) PCR and TB PCR to support microbiological diagnosis.
  • Metagenomic modalities – Metagenomic next-generation sequencing (mNGS) – is complementary to culture-based methods.

Flow chart as shown in the above article

Disclaimer: This is for academic use only. Managing an infection is complex and depends on taking multiple factors into account. Please speak to your doctor for clinical advice. This article must never be used for clinical purposes.
Scroll to Top